Company Reports Q4 Revenue of $85.165M
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 16 2026
0mins
Reports Q4 revenue $85.165M vs $59.542M last year
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ZEPP?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ZEPP
Wall Street analysts forecast ZEPP stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 8.490
Low
64.37
Averages
64.37
High
64.37
Current: 8.490
Low
64.37
Averages
64.37
High
64.37
No data
About ZEPP
Zepp Health Corp, formerly Huami Corp, is a Netherlands-based company primarily engaged in the consumer electronics and digital health technology industry. The Company focuses on developing smart wearable devices and digital health management platforms. Their key product is the Zepp Digital Health Management Platform, which is a cloud-based system integrating smart devices, biometric sensors, Artificial Intelligence (AI) chips, and data algorithms. It aims to provide users with 24/7 actionable insights to support health, fitness, and wellness management. The platform powers a range of products including smartwatches, fitness bands, smart rings, and hearables under the Amazfit and Zepp brand names. Additionally, the Company offers AI-driven services such as Zepp Aura for sound-based wellness and Zepp Clarity for hearing health. The Company has two reportable segments the Xiaomi wearable products segment and Self-branded products and others segment.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Zepp Health to Report Q1 2026 Earnings on June 8
- Earnings Report Schedule: Zepp Health is set to announce its first quarter 2026 unaudited financial results on June 8, 2026, highlighting the company's ongoing growth potential in the smart wearables and health technology sectors.
- Conference Call Timing: Management will hold a conference call at 9:30 p.m. ET on June 8, expected to attract significant attention from investors and analysts, thereby enhancing the company's transparency.
- Global User Base: To date, Zepp has shipped over 200 million devices to more than 53 million users worldwide, demonstrating its strong influence and market penetration in the smart health sector.
- Technological Platform Advantage: Leveraging its proprietary Zepp Digital Management Platform, Zepp Health provides 24/7 actionable insights and guidance to help users achieve their health goals, further solidifying its market leadership.
See More
Zepp Health to Report Q1 2026 Earnings on June 8
- Earnings Announcement: Zepp Health is set to report its unaudited financial results for Q1 2026 on June 8, 2026, reflecting the company's ongoing growth in the smart wearables and health technology sectors.
- Conference Call Schedule: Management will hold a conference call at 9:30 p.m. ET on June 8, allowing investors to dial in and stay updated on the latest company developments.
- Global User Base: To date, Zepp has shipped over 200 million units to more than 53 million users across over 150 countries, showcasing its significant impact in the smart health market.
- Technological Platform Advantage: Leveraging its proprietary Zepp Digital Management Platform, which integrates AI chips and biometric sensors, Zepp Health provides 24/7 actionable health insights and guidance, further solidifying its market leadership.
See More
Zepp Health (ZEPP) Q4 2025 Earnings Transcript
See More
Zepp Health Files 2025 Annual Report with SEC
- Annual Report Submission: On April 24, 2026, Zepp Health filed its annual report for the year ended December 31, 2025, with the SEC, reflecting the company's ongoing commitment to compliance and transparency, which is crucial for maintaining investor trust.
- Report Access: The annual report will be available on the company's investor relations website and the SEC's site, with shareholders and ADS holders able to request free hard copies, enhancing engagement and communication with investors.
- Market Leadership: Zepp Health stands as a global leader in smart wearables and health technology, leveraging brands like Amazfit, Zepp Clarity, and Zepp Aura to empower users in optimizing their health and fitness journeys, thereby solidifying its market position.
- User Base Expansion: To date, Zepp has shipped over 200 million devices and served more than 53 million users across over 150 countries and regions, demonstrating its extensive global reach and potential for continued growth.
See More
Zepp Health Approaches Breakeven Point
- Financial Performance: Zepp Health reported a loss of $40 million as of December 31, 2025, with a market cap of $235 million, indicating challenges in profitability, yet analysts remain optimistic about its future.
- Breakeven Expectations: Analysts predict that Zepp Health will achieve a profit of $1.5 million in 2026, suggesting that the company is on track to breakeven within the next 12 months, reflecting strong market confidence in its growth potential.
- Growth Rate Requirement: To meet analysts' breakeven forecasts, Zepp Health must achieve an average annual growth rate of 56%, which signals high investor confidence but also highlights potential risks associated with slower growth.
- Debt Levels: Zepp Health's debt constitutes 54% of its equity, exceeding the typical threshold of 40%, which increases investment risk, particularly as the company is not yet profitable.
See More
Zepp Health Reports Strong Q4 2025 Earnings Growth
- Significant Revenue Growth: Zepp Health reported Q4 2025 revenue of $85.2 million, a 43% year-over-year increase, with full-year revenue reaching $259 million, reflecting a 41.8% growth from 2024, indicating strong market performance and sustained growth potential.
- Margin Improvement: The gross margin for Q4 2025 reached 40.4%, expanding by 3.6 percentage points from Q4 2024, demonstrating enhanced pricing power and brand recognition, which will contribute to future profitability.
- Strong Product Sales: Amazfit branded product sales surged by 45.4% in Q4 2025, with a full-year growth of 51%, reflecting robust consumer demand for new products and laying a solid foundation for future market expansion.
- Positive Cash Flow Position: The company reported cash and cash equivalents of $113 million in Q4 2025, showcasing a positive operating cash flow that strengthens its liquidity and ability to navigate market fluctuations.
See More
Zepp Health to Report Q1 2026 Earnings on June 8
- Earnings Report Schedule: Zepp Health is set to announce its first quarter 2026 unaudited financial results on June 8, 2026, highlighting the company's ongoing growth potential in the smart wearables and health technology sectors.
- Conference Call Timing: Management will hold a conference call at 9:30 p.m. ET on June 8, expected to attract significant attention from investors and analysts, thereby enhancing the company's transparency.
- Global User Base: To date, Zepp has shipped over 200 million devices to more than 53 million users worldwide, demonstrating its strong influence and market penetration in the smart health sector.
- Technological Platform Advantage: Leveraging its proprietary Zepp Digital Management Platform, Zepp Health provides 24/7 actionable insights and guidance to help users achieve their health goals, further solidifying its market leadership.
See More
Zepp Health to Report Q1 2026 Earnings on June 8
- Earnings Announcement: Zepp Health is set to report its unaudited financial results for Q1 2026 on June 8, 2026, reflecting the company's ongoing growth in the smart wearables and health technology sectors.
- Conference Call Schedule: Management will hold a conference call at 9:30 p.m. ET on June 8, allowing investors to dial in and stay updated on the latest company developments.
- Global User Base: To date, Zepp has shipped over 200 million units to more than 53 million users across over 150 countries, showcasing its significant impact in the smart health market.
- Technological Platform Advantage: Leveraging its proprietary Zepp Digital Management Platform, which integrates AI chips and biometric sensors, Zepp Health provides 24/7 actionable health insights and guidance, further solidifying its market leadership.
See More
Zepp Health (ZEPP) Q4 2025 Earnings Transcript
See More
Zepp Health Files 2025 Annual Report with SEC
- Annual Report Submission: On April 24, 2026, Zepp Health filed its annual report for the year ended December 31, 2025, with the SEC, reflecting the company's ongoing commitment to compliance and transparency, which is crucial for maintaining investor trust.
- Report Access: The annual report will be available on the company's investor relations website and the SEC's site, with shareholders and ADS holders able to request free hard copies, enhancing engagement and communication with investors.
- Market Leadership: Zepp Health stands as a global leader in smart wearables and health technology, leveraging brands like Amazfit, Zepp Clarity, and Zepp Aura to empower users in optimizing their health and fitness journeys, thereby solidifying its market position.
- User Base Expansion: To date, Zepp has shipped over 200 million devices and served more than 53 million users across over 150 countries and regions, demonstrating its extensive global reach and potential for continued growth.
See More
Zepp Health Approaches Breakeven Point
- Financial Performance: Zepp Health reported a loss of $40 million as of December 31, 2025, with a market cap of $235 million, indicating challenges in profitability, yet analysts remain optimistic about its future.
- Breakeven Expectations: Analysts predict that Zepp Health will achieve a profit of $1.5 million in 2026, suggesting that the company is on track to breakeven within the next 12 months, reflecting strong market confidence in its growth potential.
- Growth Rate Requirement: To meet analysts' breakeven forecasts, Zepp Health must achieve an average annual growth rate of 56%, which signals high investor confidence but also highlights potential risks associated with slower growth.
- Debt Levels: Zepp Health's debt constitutes 54% of its equity, exceeding the typical threshold of 40%, which increases investment risk, particularly as the company is not yet profitable.
See More
Zepp Health Reports Strong Q4 2025 Earnings Growth
- Significant Revenue Growth: Zepp Health reported Q4 2025 revenue of $85.2 million, a 43% year-over-year increase, with full-year revenue reaching $259 million, reflecting a 41.8% growth from 2024, indicating strong market performance and sustained growth potential.
- Margin Improvement: The gross margin for Q4 2025 reached 40.4%, expanding by 3.6 percentage points from Q4 2024, demonstrating enhanced pricing power and brand recognition, which will contribute to future profitability.
- Strong Product Sales: Amazfit branded product sales surged by 45.4% in Q4 2025, with a full-year growth of 51%, reflecting robust consumer demand for new products and laying a solid foundation for future market expansion.
- Positive Cash Flow Position: The company reported cash and cash equivalents of $113 million in Q4 2025, showcasing a positive operating cash flow that strengthens its liquidity and ability to navigate market fluctuations.
See More
